Teva Pharmaceutical Industries (TEVA) News Today $18.38 -0.07 (-0.38%) Closing price 03:59 PM EasternExtended Trading$18.36 -0.02 (-0.14%) As of 06:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TEVA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Gateway Investment Advisers LLC Increases Stake in Teva Pharmaceutical Industries Ltd. $TEVASeptember 18 at 4:28 AM | marketbeat.comTeva Pharmaceutical Industries (NYSE:TEVA) Shares Down 5.1% - Should You Sell?September 17 at 10:59 PM | marketbeat.comMedincell Partner Teva to Host Investor Call on Completed Phase 3 Olanzapine LAI Data Following Psych Congress 2025 PresentationSeptember 17 at 8:00 AM | businesswire.comStrs Ohio Makes New Investment in Teva Pharmaceutical Industries Ltd. $TEVASeptember 17 at 3:26 AM | marketbeat.comTeva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS Trial For Olanzapine LAI (TEV-‘749) on September 22, 2025 After Presentations at the Psych ...September 16 at 6:14 PM | markets.businessinsider.comTeva Pharmaceutical Industries (TEVA) Attains FDA’s Fast Track Designation for EmrusolminSeptember 16 at 6:14 PM | finance.yahoo.comTeva Pharmaceutical Industries Ltd. to Present Phase 3 SOLARIS Trial Data at 2025 Psych Congress Annual MeetingSeptember 16 at 4:51 PM | quiverquant.comQTeva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS Trial For Olanzapine LAI (TEV-‘749) on September 22, 2025 After Presentations at the Psych Congress Annual meetingSeptember 16 at 4:30 PM | globenewswire.comTeva Pharmaceutical Industries Limited (TEVA)’s Emrusolmin Gains FDA Fast Track for Multiple System AtrophySeptember 16 at 9:32 AM | insidermonkey.comLingohr Asset Management GmbH Has $302,000 Stock Position in Teva Pharmaceutical Industries Ltd. $TEVASeptember 16 at 5:48 AM | marketbeat.comUBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Has $54.37 Million Stock Holdings in Teva Pharmaceutical Industries Ltd. $TEVASeptember 16 at 3:06 AM | marketbeat.comDrugmaker Corcept must face Teva lawsuit over mifepristone 'monopoly' for rare disorderSeptember 15, 2025 | reuters.comIntech Investment Management LLC Has $5.37 Million Stock Holdings in Teva Pharmaceutical Industries Ltd. $TEVASeptember 14, 2025 | marketbeat.comPlato Investment Management Ltd Sells 24,495 Shares of Teva Pharmaceutical Industries Ltd. $TEVASeptember 14, 2025 | marketbeat.comTeva Pharmaceutical Industries Ltd. $TEVA Shares Purchased by AmundiSeptember 12, 2025 | marketbeat.comZimmer Partners LP Purchases New Position in Teva Pharmaceutical Industries Ltd. $TEVASeptember 11, 2025 | marketbeat.comAxiom Investors LLC DE Makes New Investment in Teva Pharmaceutical Industries Ltd. $TEVASeptember 10, 2025 | marketbeat.comClearline Capital LP Takes Position in Teva Pharmaceutical Industries Ltd. $TEVASeptember 10, 2025 | marketbeat.comTeva Pharmaceutical Industries Limited (TEVA) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 9, 2025 | seekingalpha.comAdage Capital Partners GP L.L.C. Cuts Stock Position in Teva Pharmaceutical Industries Ltd. $TEVASeptember 9, 2025 | marketbeat.comZacks Research Has Pessimistic Outlook of TEVA Q3 EarningsSeptember 9, 2025 | americanbankingnews.comParsifal Capital Management LP Sells 169,814 Shares of Teva Pharmaceutical Industries Ltd. $TEVASeptember 8, 2025 | marketbeat.comGraham Capital Management L.P. Cuts Holdings in Teva Pharmaceutical Industries Ltd. $TEVASeptember 8, 2025 | marketbeat.comTeva Pharmaceutical Industries Ltd. $TEVA Shares Acquired by NWI Management LPSeptember 7, 2025 | marketbeat.comIon Asset Management Ltd. Acquires 2,383,500 Shares of Teva Pharmaceutical Industries Ltd. $TEVASeptember 7, 2025 | marketbeat.comCanada Pension Plan Investment Board Has $2.32 Million Stock Position in Teva Pharmaceutical Industries Ltd. $TEVASeptember 7, 2025 | marketbeat.comTeva Pharmaceutical Industries Ltd. $TEVA is Cutter Capital Management LP's 10th Largest PositionSeptember 6, 2025 | marketbeat.comBanque Transatlantique SA Makes New $473,000 Investment in Teva Pharmaceutical Industries Ltd. $TEVASeptember 6, 2025 | marketbeat.comAlyeska Investment Group L.P. Decreases Holdings in Teva Pharmaceutical Industries Ltd. $TEVASeptember 6, 2025 | marketbeat.comFirst Manhattan CO. LLC. Has $333,000 Position in Teva Pharmaceutical Industries Ltd. $TEVASeptember 6, 2025 | marketbeat.comColorado must face Teva's lawsuit over free allergy pen lawSeptember 5, 2025 | reuters.comArdsley Advisory Partners LP Grows Stake in Teva Pharmaceutical Industries Ltd. $TEVASeptember 5, 2025 | marketbeat.comMaverick Capital Ltd. Purchases 16,137 Shares of Teva Pharmaceutical Industries Ltd. $TEVASeptember 5, 2025 | marketbeat.comTrexquant Investment LP Has $3.13 Million Holdings in Teva Pharmaceutical Industries Ltd. $TEVASeptember 5, 2025 | marketbeat.comADAR1 Capital Management LLC Increases Position in Teva Pharmaceutical Industries Ltd. $TEVASeptember 4, 2025 | marketbeat.comTeva Pharmaceutical Industries Ltd. $TEVA Shares Acquired by Retirement Planning Co of New England Inc.September 3, 2025 | marketbeat.comDriehaus Capital Management LLC Cuts Stock Position in Teva Pharmaceutical Industries Ltd. $TEVASeptember 3, 2025 | marketbeat.comTeva Pharmaceutical Industries Ltd. CEO Richard Francis to Present at Upcoming Investor Conferences in September 2025September 2, 2025 | quiverquant.comQTeva to Present at Morgan Stanley Global Healthcare Conference and Bank of America Global Healthcare Conference in SeptemberSeptember 2, 2025 | globenewswire.comTeva Pharmaceutical Industries Ltd. $TEVA Stock Holdings Lessened by Beck Mack & Oliver LLCSeptember 2, 2025 | marketbeat.comWellington Management Group LLP Sells 47,776 Shares of Teva Pharmaceutical Industries Ltd. $TEVASeptember 2, 2025 | marketbeat.comIron Triangle Partners LP Has $34.09 Million Stake in Teva Pharmaceutical Industries Ltd. $TEVAAugust 31, 2025 | marketbeat.comGabelli Funds LLC Boosts Position in Teva Pharmaceutical Industries Ltd. $TEVAAugust 31, 2025 | marketbeat.comTeva Pharmaceutical Industries (TEVA) Announces the FDA Approval and U.S. Launch of Generic SaxendaAugust 31, 2025 | finance.yahoo.comTri Locum Partners LP Sells 1,362,108 Shares of Teva Pharmaceutical Industries Ltd. $TEVAAugust 30, 2025 | marketbeat.comTeva Pharmaceutical Industries Limited (TEVA) Gains FDA Nod for Pediatric Migraine Drug AJOVYAugust 29, 2025 | finance.yahoo.comAPG Asset Management N.V. Decreases Stock Position in Teva Pharmaceutical Industries Ltd. $TEVAAugust 29, 2025 | marketbeat.comTeva stock rises on launch of first generic weight loss GLP-1 drugAugust 28, 2025 | in.investing.comTEVA Trumpets Saxenda, Stocks Eke HigherAugust 28, 2025 | baystreet.caTeva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight LossAugust 28, 2025 | finance.yahoo.com Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TEVA Media Mentions By Week TEVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TEVA News Sentiment▼0.920.79▲Average Medical News Sentiment TEVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TEVA Articles This Week▼1416▲TEVA Articles Average Week Get the Latest News and Ratings for TEVA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Teva Pharmaceutical Industries and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies GSK News TAK News ARGX News ONC News INSM News BNTX News GMAB News SMMT News RDY News ASND News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:TEVA) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teva Pharmaceutical Industries Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Teva Pharmaceutical Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TEVA Stock Alerts